NCT01725555View on ClinicalTrials.gov

A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Solid TumorsHematological Malignancies
Interventions
DRUG

Fasted treatment: AXL1717

DRUG

Fed treatment: AXL1717

Trial Locations (1)

Unknown

KFUE, Uppsala

Sponsors

Lead Sponsor

Axelar AB
All Listed Sponsors
lead

Axelar AB

INDUSTRY

NCT01725555 - A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors | Biotech Hunter | Biotech Hunter